课题基金 / 基金详情

项目摘要

项目成果

Ruby Yanru Chen-Tsai的其他基金

相关文献

中文摘要
翻译
转基因和基因敲除小鼠共享资源于1996年在哈佛大学建立。 药本共享资源的总体目标是提供转基因小鼠 以具有成本效益的价格向斯坦福大学癌症中心的研究人员提供模型和支持技术。这 共享资源为实现可持续发展提供了必要的科学技术基础和物质基础, 开展转基因、基因打靶和胚胎干细胞研究。共享资源服务于 通过提供广泛的小鼠胚胎和干细胞在推进癌症研究中发挥重要作用 细胞操作和显微注射服务作为一种高度专业化的技术。的 共享资源的目标是: 在创建和表征转基因小鼠的各个方面提供咨询 通过显微注射生产转基因和基因敲除小鼠 操作小鼠胚胎干细胞用于基因靶向 <$提供与转基因小鼠生产相关的分子和生物试剂 通过提供这些服务,可以节省大量费用,提高效率,促进科学进步 通过一个集中的设施。在过去的5年里,共享资源已经生成了500多个鼠标模型。 年,每个都有多个独立的行。共享资源的服务得到了 在同行评审期刊上发表了50多篇论文。在2005财政年度,有192项服务请求, 癌症中心成员占总使用量的56%。癌症中心成员代表 十个程序中有八个使用了共享资源。共享资源的未来计划包括 实施体细胞核移植和四倍体胚泡互补服务,以及 新ES细胞系的衍生。
英文摘要
The Transgenic and Knockout Mouse Shared Resource was established in 1996 at the School of Medicine. The overall objective of this Shared Resource is to provide genetically modified mouse models and supporting technologies to Stanford Cancer Center investigators at cost-effective rates. This Shared Resource provides the necessary scientific and technical foundation and physical plant to conduct transgenic, gene targeting and embryonic stem cell research. The Shared Resource serves an important role in advancing cancer research by providing a wide spectrum of mouse embryo and stem cell manipulation and microinjection services to investigators as a highly specialized technology. The objectives of the Shared Resource are to: ¿ Consult in all aspects of creating and characterizing genetically modified mice ¿ Produce transgenic and knockout mice by microinjection ¿ Manipulate mouse embryonic stem cells for gene targeting ¿ Provide molecular and biological reagents associated with production of genetically modified mice Substantial cost savings, efficiencies and scientific advances accrue from providing these services through a centralized facility. The Shared Resource has generated over 500 mouse models in the last 5 years, each with multiple independent lines. The Shared Resource's services were acknowledged in more than 50 publications in peer-reviewed journals. In fiscal year 2005, there were 192 service requests, with Cancer Center members accounting for 56% of overall use. Cancer Center members representing eight out of ten Programs utilized the Shared Resource. Future plans for the Shared Resource include implementation of somatic cell nuclear transfer and tetraploid blastocyst complementation services, and derivation of new ES cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Gene Insertion by Directed Evolution of ΦC31 Integrase for Therapeutic Gene Editing
  • 批准号:
    9906961
  • 项目类别:
  • 资助金额:
    $22.49万
  • 财政年份:
    2020
  • 负责人:
    Ruby Yanru Chen-Tsai
  • 依托单位:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
  • 批准号:
    10177096
  • 项目类别:
  • 资助金额:
    $111.6万
  • 财政年份:
    2020
  • 负责人:
    Ruby Yanru Chen-Tsai
  • 依托单位:
Targeted Gene Insertion by Directed Evolution of æC31 Integrase for Therapeutic Gene Editing
  • 批准号:
    10227267
  • 项目类别:
  • 资助金额:
    $63.42万
  • 财政年份:
    2020
  • 负责人:
    Ruby Yanru Chen-Tsai
  • 依托单位:
Development of novel rat models for site-specific transgene integration
  • 批准号:
    8643473
  • 项目类别:
  • 资助金额:
    $21.79万
  • 财政年份:
    2014
  • 负责人:
    Ruby Yanru Chen-Tsai
  • 依托单位: